CarboHyde

CarboHyde is a private pre-clinical pharmaceutical start-up company specializing in the development of carbohydrate-based APIs. Our team comprises a small group of seasoned scientists with over 50 years of cumulative experience in carbohydrate chemistry, analysis, and pharmaceutical development.
The company’s core focus is neurodegenerative diseases, yet we also have other pre-clinical programs in various unmet medical indications.

Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CROs) and other companies focusing on CMC and clinical development to make our drug development process efficient.

CarboHyde’s management team has extensive experience in medicinal chemistry, marketing, and pharmaceutical development. In addition, CarboHyde is supported by experienced advisers, consultants, and carbohydrate veterans.